Acinetobacter baumannii is a notorious pathogen in health care settings around the world, primarily due to high resistance to antibiotics. A. baumannii also shows an impressive capability to adapt to harsh conditions in clinical settings, which contributes to its persistence in such conditions. Following their traditional role, the Two Component Systems (TCSs) present in A. baumannii play a crucial role in sensing and adapting to the changing environmental conditions. This provides A. baumannii with a greater chance of survival even in unfavorable conditions. Since all the TCSs characterized to date in A. baumannii play a role in its antibiotic resistance and virulence, understanding the underlying molecular mechanisms behind TCSs can help ...
Abstract Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions ...
Acinetobacter baumannii is a Gram-negative bacillus that causes multiple infections that can become ...
Background: Resistance to multiple drugs is one of the biggest challenges in managing infectious dis...
During the past few decades Acinetobacter baumannii has evolved from being a commensal dweller of he...
Multidrug resistant microorganisms are forecast to become the single biggest challenge to medical ca...
Acinetobacter baumannii is an important opportunistic pathogen of hospital acquired infection, parti...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Being a multidrug-resistant and an invasiv...
Background: Acinetobacter baumannii is one of the most important opportunistic pathogens responsible...
 Objective: Multiple drug resistance (MDR) in bacteria, particularly Gram-negative bacilli, has sig...
Thesis by publication.Includes bibliographical references.Chapter 1. Introduction -- Chapter 2. Rapi...
The emergence of infections caused by Acinetobacter baumannii, a multidrug-resistant bacterium, has ...
Acinetobacter baumannii is an opportunistic pathogen prevalent in nosocomial infections, most common...
Acinetobacter baumannii is regarded as a life-threatening pathogen associated with community-acquire...
The Gram-negative opportunistic bacterium Acinetobacter baumannii is a significant cause of hospital...
International audienceABSTRACT : Acinetobacter baumannii is a nosocomial pathogen of increasing impo...
Abstract Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions ...
Acinetobacter baumannii is a Gram-negative bacillus that causes multiple infections that can become ...
Background: Resistance to multiple drugs is one of the biggest challenges in managing infectious dis...
During the past few decades Acinetobacter baumannii has evolved from being a commensal dweller of he...
Multidrug resistant microorganisms are forecast to become the single biggest challenge to medical ca...
Acinetobacter baumannii is an important opportunistic pathogen of hospital acquired infection, parti...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Being a multidrug-resistant and an invasiv...
Background: Acinetobacter baumannii is one of the most important opportunistic pathogens responsible...
 Objective: Multiple drug resistance (MDR) in bacteria, particularly Gram-negative bacilli, has sig...
Thesis by publication.Includes bibliographical references.Chapter 1. Introduction -- Chapter 2. Rapi...
The emergence of infections caused by Acinetobacter baumannii, a multidrug-resistant bacterium, has ...
Acinetobacter baumannii is an opportunistic pathogen prevalent in nosocomial infections, most common...
Acinetobacter baumannii is regarded as a life-threatening pathogen associated with community-acquire...
The Gram-negative opportunistic bacterium Acinetobacter baumannii is a significant cause of hospital...
International audienceABSTRACT : Acinetobacter baumannii is a nosocomial pathogen of increasing impo...
Abstract Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions ...
Acinetobacter baumannii is a Gram-negative bacillus that causes multiple infections that can become ...
Background: Resistance to multiple drugs is one of the biggest challenges in managing infectious dis...